Tela Bio (TELA) stock drops as Q4 2024 and 2025 outlook miss expectations, prompting Piper Sandler to downgrade it shares. Read more here.

Shares of small electric vehicle (EV) maker Rivian Automotive Inc. (NASDAQ: RIVN) have performed poorly recently, and a Wall ...

Piper Sandler is sticking to its S&P 500 (SP500) year-end target of 6,600 points, despite the recent dip in the benchmark ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Skye Bioscience (SKYE – Research Report), with a ...

Piper Sandler analyst Anna Andreeva reiterated a Buy rating on Nike (NKE – Research Report) today and set a price target of $90.00. The ...

In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price ...

Piper Sandler analyst David Amsellem lowered the firm’s price target on Amphastar (AMPH) to $32 from $36 and keeps a Neutral rating on the ...

On top of that, the big news in the EV space Thursday had to do with a recall. Tesla announced it was recalling more than ...

Piper Sandler analyst Jason Bednar maintained a Hold rating on Solventum Corporation (SOLV – Research Report) today and set a price target of ...

Piper Sandler analyst Alexander Potter raised his firm’s price target on General Motors (GM) on the heels of downgrading ...

2-Year U.S. Treasury Note Continuous Contract $103.504-0.031-0.03% 5-Year U.S. Treasury Note Continuous Contract $107.945-0.070-0.07% 10-Year U.S. Treasury Note Continuous Contract $111.063-0.109 ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...